In The News

September 2018

4D Molecular Therapeutics Raises $90 Million Series B Fin...

More

July 2018

MedImmune and 4D Molecular Therapeutics Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease

More

4DMT In The Media

Click below to read more

More